Regulation
The FDA vs. Commercial Speech
How restricting the promotion of "off-label" pharmaceutical use puts doctors and patients at risk
The EPA vs. the Constitution
The Supreme Court prepares to hear a major Fifth Amendment case.
How restricting the promotion of "off-label" pharmaceutical use puts doctors and patients at risk
The Supreme Court prepares to hear a major Fifth Amendment case.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10
